Comparative Study of Three Collagen Membranes: 1 Non-cross-linked and 2 Cross-linked
NCT ID: NCT06944639
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
20 participants
INTERVENTIONAL
2025-04-28
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, the membranes will be placed in the mouth in a specific area near the gums of the upper back teeth. The study is designed so that neither the patients nor the researchers evaluating the results will know which membrane is which (this is called a double-blind study). Over time, researchers will measure how much each membrane has broken down. This information may help improve treatment planning and patient outcomes in dental care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regenerative Treatment of Peri-implantitis
NCT06153212
Regenerative Outcomes for Peri-implant Bony Defects Using Amnion-chorion Barrier vs. Collagen Membrane
NCT07032259
Evaluation of Cross-linked Collagen Membrane With and Without Silk Fibroin Around Immediate Dental Implants
NCT06552065
Comparison of Two Collagen Membranes for Bone Augmentation Around Dental Implants Restored with Monolithic Zirconia Single Crowns
NCT06724783
the Peri-implant Tissue Changes Around Implants in the Esthetic Zone Using Demineralized Dentin Graft vs Xenograft
NCT06164353
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the first visit, digital intraoral impressions and clinical pictures will be taken, periodontal charts filled, and oral hygiene sessions conducted by trained hygienists. Two weeks later, during the second visit, patients will be reexamined to exclude any signs of inflammation. Membranes will be cut to a uniform size of 8\*10 mm by an assistant prior to placement. They will be placed in a randomized mesiodistal order on the buccal mucosa, apical to the gingival margins of maxillary premolar and molar teeth (the future position will be evaluated on the intraoral scanned model). To fix the membranes, a vestibular sling suture without any perforation (PTFE 3/0) will be used. A light-cured periodontal dressing (Barricaid, Dentsply Caulk, Dentsply Int. Inc., York, PA, USA) will be placed on the buccal site to fix a knot and two other points on the membrane to fix it to the suture. Standard intraoral pictures will be taken. Patients will be instructed to avoid hard foods, brushing in the area of the membrane, and excessive movements to prevent dislocation of the structure. The same oral hygiene products will be provided to all patients.
Follow-up visits will be scheduled at 3, 7 and 10 days. At the 10-day follow-up clinical evaluation will be performed to assess any perforation. A set of pictures will be taken. Membranes integrity will be analyzed by two blinded examiners using a Scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OSSIX - BioMend - Jason
Possible unique ordering of the 3 different membranes to which participants may be randomized
Membrane Jason MB GmbH Non-cross-linked (NCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linked
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
BioMend - OSSIX - Jason
Possible unique ordering of the 3 different membranes to which participants may be randomized
Membrane Jason MB GmbH Non-cross-linked (NCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linked
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
BioMend - Jason - OSSIX
Possible unique ordering of the 3 different membranes to which participants may be randomized
Membrane Jason MB GmbH Non-cross-linked (NCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linked
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Jason - OSSIX - BioMend
Possible unique ordering of the 3 different membranes to which participants may be randomized
Membrane Jason MB GmbH Non-cross-linked (NCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linked
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Jason - BioMend - OSSIX
Possible unique ordering of the 3 different membranes to which participants may be randomized
Membrane Jason MB GmbH Non-cross-linked (NCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linked
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
OSSIX - Jason - BioMend
Possible unique ordering of the 3 different membranes to which participants may be randomized
Membrane Jason MB GmbH Non-cross-linked (NCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linked
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Membrane Jason MB GmbH Non-cross-linked (NCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linked
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good overall health (ASA I or ASA II)
* Good oral health
Exclusion Criteria
* Individuals with uncontrolled chronic diseases or immunocompromised.
* Pregnant Patients
* Patients who are currently breastfeeding
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dentsply Sirona Inc.
INDUSTRY
Andrea Ravida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Ravida
Assistant Professor and Program director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Ravida, DDS, MS, PhD
Role: PRINCIPAL_INVESTIGATOR
Program Director of the Periodontics and Implant Dentistry Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pittsburgh, School of Dental Medicine
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Klinger A, Asad R, Shapira L, Zubery Y. In vivo degradation of collagen barrier membranes exposed to the oral cavity. Clin Oral Implants Res. 2010 Aug;21(8):873-6. doi: 10.1111/j.1600-0501.2010.01921.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY24100119
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.